The nation of Zimbabwe has rejected a significant US health deal valued at 367 million US dollars (£272m) spanning five years due to Washington's request for sensitive data.
This move was revealed after a official document from December was leaked, revealing that President Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government spokesperson has since stated that the US was seeking health data for research and profit while was unwilling to guarantee the benefits from future treatments.
"We must now begin the challenging and unfortunate process of scaling back our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged more negotiations to reach a agreement acceptable to both sides so the nation's vital HIV programme can continue.
Broader Background
This rejection comes after a similar case in Kenya, where a high court blocked a similar health funding agreement after concerns were filed about the security of Kenyans' health data.
After returning to office last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
USAID had managed aid for the American government, but Trump argued its expenditure was "inefficient" and his government was pursuing direct bilateral deals to enhance openness and responsibility.
According to reports, 16 nations in Africa have so far agreed to these new health pacts, representing over $18.3bn in new funding.
Details of the Declined Agreement
This assistance for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership could have provided significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment via American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to share its genetic material and health information for a long time, with no corresponding guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"In essence, our nation would provide the raw materials for scientific discovery with no certainty that the final treatments would be available to our citizens should a future health crisis emerge."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were upending systems already established via the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with potential global health emergencies.
"This mechanism is designed to guarantee that when a nation contributes its information, the benefits – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome ongoing dialogue with our American counterparts on how future collaboration could be structured in a manner that respects the independence and interests of both nations."
Medical Community Response
A leading public health body expressed it acknowledged the government's concerns, but suggested that talks must proceed considering much of the country's HIV programmes were funded by foreign aid.
"Where technical issues arise, such as those relating to data governance or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," it added.
The situation highlights the continuing debate between receiving crucial foreign assistance and safeguarding local interests in an ever more data-driven world.